Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-06-26T19:56:40.287Z Has data issue: false hasContentIssue false

Sedation for paediatric transcatheter atrial septal defect closure: comparison of two sedation protocols

Published online by Cambridge University Press:  09 September 2013

Ayşe Ülgey*
Affiliation:
Department of Anaesthesiology, Erciyes University Medical Faculty, Kayseri, Turkey
Adnan Bayram
Affiliation:
Department of Anaesthesiology, Erciyes University Medical Faculty, Kayseri, Turkey
Işın Güneş
Affiliation:
Department of Anaesthesiology, Erciyes University Medical Faculty, Kayseri, Turkey
Recep Aksu
Affiliation:
Department of Anaesthesiology, Erciyes University Medical Faculty, Kayseri, Turkey
Cihangir Bicer
Affiliation:
Department of Anaesthesiology, Erciyes University Medical Faculty, Kayseri, Turkey
Aynur Akin
Affiliation:
Department of Anaesthesiology, Erciyes University Medical Faculty, Kayseri, Turkey
Ali Baykan
Affiliation:
Department of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
Nazmi Narin
Affiliation:
Department of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
Adem Boyaci
Affiliation:
Department of Anaesthesiology, Erciyes University Medical Faculty, Kayseri, Turkey
*
Correspondence to: Dr A. Ülgey, MD, Assistant professor, M. Şimşek C. Hisar Geçidi. Serdem Apt. No: 8/31 Melikgazi, Kayseri 38030, Turkey. Tel: +00 903 522 076/666/24043/00 905 378 201 751; Fax: +00 903 52 437 7333; E-mail: aulgey@erciyes.edu.tr; aulgey38@gmail.com

Abstract

Aim: This study aimed to compare the effects of dexmedetomidine–propofol and ketamine–propofol sedation on haemodynamic stability, immobility, and recovery time in children who underwent transcatheter closure of atrial septal defects. Methods: In all, 46 children scheduled for transcatheter closure of atrial septal defects (n = 46) were included. The dexmedetomidine–propofol group (n = 23) received dexmedetomidine (1 μg/kg) and propofol (1 mg/kg) for induction, followed by dexmedetomidine (0.5 μg/kg/hour) and propofol (100 μg/kg/minute) for maintenance. The ketamine–propofol group (n = 23) received ketamine (1 mg/kg) and propofol (1 mg/kg) for induction, followed by ketamine (1 mg/kg) and propofol (100 μg/kg/minute) for maintenance. Results: In all, 11 patients in the dexmedetomidine group (47.8%) and one patient (4.3%) in the ketamine group demonstrated a decrease ≥20% from the baseline in mean arterial pressure (p = 0.01). Heart rates decreased ≥20% from the baseline value in 10 patients (43.4%) in the dexmedetomidine group and three patients (13%) in the ketamine group (p = 0.047). Heart rate values were observed to be lower in the dexmedetomidine group throughout the procedure after the first 10 minutes. The number of patients requiring additional propofol was higher in the dexmedetomidine group (p = 0.01). The recovery times were similar in the two groups – 15.86 ± 6.50 minutes in the dexmedetomidine group and 19.65 ± 8.19 minutes in the ketamine group; p = 0.09. Conclusion: The ketamine–propofol combination was less likely to induce haemodynamic instability, with no significant change in recovery times, compared with the dexmedetomidine–propofol combination. The ketamine–propofol combination provided good conditions for the intervention.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Butera, G, Zoccai, B, Sangiorgi, G, et al. Percutaneus versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. Eurointervention 2011; 7: 377385.Google Scholar
2. Kogan, A, Efrat, R, Katz, J, Vidne, BA. Propofol mixture for anesthesia in pediatric patients undergoing cardiac catheterization. J Cardiothorac Vasc Anesth 2003; 17: 691693.CrossRefGoogle ScholarPubMed
3. Akın, A, Esmaoğlu, A, Güler, G, Demircioglu, R, Narin, N, Boyaci, A. Propofol and propofol ketamine in pediatric patients undergoing cardiac catheterization. Pediatr Cardiol 2005; 26: 553557.CrossRefGoogle ScholarPubMed
4. Tosun, Z, Akın, A, Güler, G, Esmaoglu, A, Boyaci, A. Dexmedetomidine – ketamin anmd propofol ketamin combination for anesthesia in spontaeously breathing pediatric patient undergoing cardiac catheterization. J Cardiothorac Vasc Anesth 2006; l20: 515519.Google Scholar
5. Mester, R, Easley, B, Bredy, KM, Chilson, K, Tobias, JD. Monitored anesthesia care with a combination of ketamine and dexmedetomidine during cardiac catheterization. Am J Ther 2008; 15: 2430.CrossRefGoogle ScholarPubMed
6. Munro, HM, Tirotta, JF, Felix, DE, et al. Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children. Pediatr Anesth 2007; 17: 109112.Google Scholar
7. Öklü, E, Bulutcu, FS, Özbek, U, Ozbek, U, Cakali, E, Bayindir, O. Which anesthetic agent alters the hemodynamic status during pediatric catheterization? Comparison of propofol versus ketamine. J Cardiothorac Vasc Anesth 2003; 17: 686690.Google Scholar
8. Steward, DJ. A simlified scoring system for the postoperative recovery room. Can Anaesth Soc J 1975; 22: 111113.CrossRefGoogle Scholar
9. Gayatri, P, Suneel, PR, Sinha, PK. Evaluation of propofol – ketamine anesthesia for children undergoing cardiac catheterization procedures. J Intervent Cardiol 2007; 20: 158163.CrossRefGoogle ScholarPubMed
10. Koruk, S, Mizrak, A, Kaya Ugur, B, Ilhan, O, Baspinar, O, Oner, U. Propofol/dexmedetomidine and propofol/ketamine combinations for anesthesia in pediatric patients undergoing transcatheter atrial septal defect closure: a prospective randomized study. Clin Ther 2010; 32: 701709.CrossRefGoogle ScholarPubMed